However, due to the importance of PI3K/AKT signaling in cancer [63,64,65], PI3Kδ could represent a highly attractive drug target also for the treatment of skin tumors and, in particular, of non-melanoma skin cancers, characterized by hyperproliferation of epidermal keratinocytes. This evidence concerns the gene AKT1 and melanoma.